Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 24, 2007
A live webcast and replay of the May 2 conference session will be available
-
Apr 23, 2007
"I am pleased we came in at the upper end of our ranges for sales and EPS for the quarter," said Jim Tobin, President and Chief Executive Officer
-
Apr 17, 2007
Product provides enhanced control for accessing desired vessel location
-
Apr 16, 2007
A live webcast and replay of the April 23 conference call will be available.
-
Apr 16, 2007
Company has resolved deficiencies in the warning letter issued by the U.S. Food and Drug Administration (FDA) to the Guidant Corporation
-
Apr 3, 2007
Company plans to launch the product after reimbursement approval is granted
-
Apr 2, 2007
Trial is designed to identify and investigate clinically relevant endpoints for evaluating the efficacy and durability of endovascular treatment of brain aneurysms
-
Mar 26, 2007
BTK CHILL study demonstrates high rate of limb protection at one year
-
Mar 25, 2007
TAXUS® Express2™ paclitaxel-eluting coronary stent system met its primary endpoint in the treatment of in-stent restenosis
-
Mar 25, 2007
Two-year review of TAXUS Stent safety data presented at ACC